|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Cesca Therapeutics
| | | Phone: | (800) 783-8357 | Fax: | (916) 858-5199 | Year Established: | 2014 | Ticker: | KOOL | Exchange: | NASDAQ | Main Contact: | Xiaochun “Chris” Xu, Chairman & Interim CEO | | Other Contacts: | Kim Ellner, VP, Manufacturing and Global Supply Chain Mike Bruch, Interim CFO
| | Company Description | Cesca Therapeutics (Clinical Excellence in Stem Cell Applications), formerly ThermoGenesis, was created through the merger of ThermoGenesis and TotipotentRx. The combined company joins ThermoGenesis' best-in-class cell-based device technologies with TotipotentRx's cell therapeutic kits and protocols to offer clinically validated, commercially scalable, point-of-care autologous cell therapies for major therapeutic markets. Cesca Therapeutics is expected to become one of the first fully integrated regenerative medicine companies. | |
|
|
|
|
|